A carregar...

Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets

Whilst the majority of individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of COVID-19, experience mild to moderate symptoms, approximately 20% develop severe respiratory complications that may progress to acute respiratory distress syndrome...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Hazeldine, Jon, Lord, Janet M.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8206563/
https://ncbi.nlm.nih.gov/pubmed/34149717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.680134
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!